TDAC
Translational Development Acquisition Corp. Ordinary Shares
NASDAQ: TDAC · FINANCIAL SERVICES · SHELL COMPANIES
$10.64
+0.09% today
Updated 2026-05-01
Market cap
$233.31M
P/E ratio
36.72
P/S ratio
—
EPS (TTM)
$0.29
Dividend yield
—
52W range
$10 – $11
Volume
0.0M
Translational Development Acquisition Corp. Ordinary Shares (TDAC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-97164.00 | $-204.00 | $-851446.00 | $-608387.00 |
| Capital expenditures | $4.00 | $0.00 | $4.00 | $3.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | — | — | — | — |
| Free cash flow | $-97168.00 | $-204.00 | $-851450.00 | $-608390.00 |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | $125346.00 | $7.31M |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |